221 related articles for article (PubMed ID: 36017686)
1. Comparison between outcomes of IgA nephropathy with nephrotic-range proteinuria and nephrotic syndrome: do podocytes play a role?
Chen Y; Yang A; Hou Y; Liu L; Lin J; Huang X; Li J; Liu X; Lu F; Lin Q; Yang H; Yue S; Jiang S; Wang L; Zou C
Ren Fail; 2022 Dec; 44(1):1443-1453. PubMed ID: 36017686
[TBL] [Abstract][Full Text] [Related]
2. The significance of foot process effacement in immunoglobulin a nephropathy: clinicopathologic study of 161 cases with light, immunofluorescence and electron microscopic studies.
Sharma SG; Spencer T; Gokden N
Ultrastruct Pathol; 2010 Oct; 34(5):269-72. PubMed ID: 20568984
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of massive proteinuria in primary IgA nephropathy with and without nephrotic syndrome: a single center cohort study.
Hu Y; Huang Z; Cao Q; Chen B; Xu S; Qiu W; You X; Zhang J; Chen C
Ren Fail; 2023; 45(2):2267138. PubMed ID: 37850851
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome.
Han X; Xiao Y; Tang Y; Zheng X; Anwar M; Qin W
Clin Exp Med; 2019 Nov; 19(4):479-486. PubMed ID: 31542837
[TBL] [Abstract][Full Text] [Related]
5. IgA nephropathy with presentation of nephrotic syndrome at onset in children.
Shima Y; Nakanishi K; Sato M; Hama T; Mukaiyama H; Togawa H; Tanaka R; Nozu K; Sako M; Iijima K; Suzuki H; Yoshikawa N
Pediatr Nephrol; 2017 Mar; 32(3):457-465. PubMed ID: 27714465
[TBL] [Abstract][Full Text] [Related]
6. The difference between patients with nephrotic syndrome and nephrotic-range proteinuria in IgA nephropathy: a propensity score matched cohort study.
Li H; Wang F; Jia J; Yan T; Liu Y; Lin S
BMC Nephrol; 2022 Apr; 23(1):163. PubMed ID: 35488221
[TBL] [Abstract][Full Text] [Related]
7. Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.
Mohd R; Mohammad Kazmin NE; Abdul Cader R; Abd Shukor N; Wong YP; Shah SA; Alfian N
PLoS One; 2021; 16(4):e0249592. PubMed ID: 33831052
[TBL] [Abstract][Full Text] [Related]
8. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
9. Severity of nephrotic IgA nephropathy according to the Oxford classification.
Moriyama T; Nakayama K; Iwasaki C; Ochi A; Tsuruta Y; Itabashi M; Tsukada M; Takei T; Uchida K; Nitta K
Int Urol Nephrol; 2012 Aug; 44(4):1177-84. PubMed ID: 22231129
[TBL] [Abstract][Full Text] [Related]
10. IgA nephropathy with minimal change disease.
Herlitz LC; Bomback AS; Stokes MB; Radhakrishnan J; D'Agati VD; Markowitz GS
Clin J Am Soc Nephrol; 2014 Jun; 9(6):1033-9. PubMed ID: 24721885
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
[TBL] [Abstract][Full Text] [Related]
12. Podocyte number predicts progression of proteinuria in IgA nephropathy.
Xu L; Yang HC; Hao CM; Lin ST; Gu Y; Ma J
Mod Pathol; 2010 Sep; 23(9):1241-50. PubMed ID: 20495534
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and outcomes of IgA nephropathy with nephrotic syndrome.
Kim JK; Kim JH; Lee SC; Kang EW; Chang TI; Moon SJ; Yoon SY; Yoo TH; Kang SW; Choi KH; Han DS; Kie JH; Lim BJ; Jeong HJ; Han SH
Clin J Am Soc Nephrol; 2012 Mar; 7(3):427-36. PubMed ID: 22223610
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.
Chakera A; MacEwen C; Bellur SS; Chompuk LO; Lunn D; Roberts ISD
J Nephrol; 2016 Jun; 29(3):367-375. PubMed ID: 26318019
[TBL] [Abstract][Full Text] [Related]
15. Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
Bellur SS; Lepeytre F; Vorobyeva O; Troyanov S; Cook HT; Roberts IS;
Kidney Int; 2017 Jan; 91(1):235-243. PubMed ID: 27914703
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study.
Liu S; Lu Z; Fu Z; Li H; Gui C; Deng Y
Kidney Blood Press Res; 2023; 48(1):186-193. PubMed ID: 37062274
[TBL] [Abstract][Full Text] [Related]
17. Key pathological features characterize minimal change disease-like IgA nephropathy.
Wang TY; Chang FP; Yang AH; Ka SM; Chen A; Hsieh JT; Chen FY; Lee TL; Tseng PY; Tsai MT; Li SY; Yang CY; Chen JY; Lin CC; Tarng DC
PLoS One; 2023; 18(7):e0288384. PubMed ID: 37471324
[TBL] [Abstract][Full Text] [Related]
18. Correlation of proteinuria with podocyte foot process effacement in IgA nephropathy: an ultrastructural study.
Tewari R; Nada R; Rayat CS; Boruah D; Dudeja P; Joshi K; Sakhuja V
Ultrastruct Pathol; 2015 Apr; 39(2):147-51. PubMed ID: 25268180
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
Yao Y; Liu JC; Xiao HJ; Huang JP; Yang JY
Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):412-6. PubMed ID: 15265422
[TBL] [Abstract][Full Text] [Related]
20. Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology.
Lin Z; Liu L; Zhang R; Lin X; Lu F; Bao K; Wang L; Lin Q; Mai J; Cao Y; Yang H; Liu X; Zou C
Am J Nephrol; 2021; 52(6):507-518. PubMed ID: 34134110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
